Pricing Log in Create free account

RxSight, Inc. (RXST) vs Neuronetics, Inc. (STIM)

RxSight, Inc. and Neuronetics, Inc. are both Medical Devices companies. RxSight, Inc. and Neuronetics, Inc. are of similar size ($190.4M and $185.2M). Neuronetics, Inc. grew revenue faster over the last twelve months: 23.0% against −14.3%. Neuronetics, Inc. has the higher net margin (−14.5% vs −43.8%) and the higher return on invested capital (−16.7% vs −16,845.7%). Across the 18 metrics below, RxSight, Inc. leads on 10 and Neuronetics, Inc. on 8.

Valuation

Metric RXST STIM Medical Devices median
P/E n/m n/m 25.58
P/S 1.52 1.18 2.54
P/B 0.72 8.39 2.48
Price to free cash flow 9.91 n/m 28.81
EV/EBITDA 0.77 n/m 11.51
EV/Sales (0.41) 1.47 2.72
Earnings yield (28.87%) (13.52%) (12.82%)
Free cash flow yield 10.09% (4.90%) (8.18%)

Profitability

Metric RXST STIM Medical Devices median
Gross margin 76.13% 50.68% 57.76%
Operating margin (50.44%) (9.39%) (15.07%)
Net margin (43.80%) (14.45%) (14.45%)
Free cash flow margin 15.30% (5.18%) (3.88%)
Return on equity (20.10%) (85.85%) (10.35%)
Return on assets (16.44%) (16.64%) (17.26%)
Return on invested capital (16,845.67%) (16.72%) (5.27%)

Growth

Metric RXST STIM Medical Devices median
Revenue growth (TTM) (14.26%) 23.01% 10.41%
EPS growth (last fiscal year) (33.80%) 56.93% 28.17%
Revenue growth, 5-year CAGR 55.74% 24.81% 15.74%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric RXST STIM Medical Devices median
Debt to equity 0.00 2.76 0.04
Current ratio 4.20 2.01 2.74
Net debt to EBITDA 4.27 (1.12) 0.54

Dividend

Metric RXST STIM Medical Devices median
Dividend yield — — 1.02%
Payout ratio — — 0.37

Size

Metric RXST STIM Medical Devices median
Market cap 190.36m 185.16m 239.53m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack